Yuping Sun

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 253 citations · Full text

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study

Jifeng Feng, Dihong Tang, Jing Wang et al. · Clinical Cancer Research · 2022 · 51 citations

Tumor‐derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer

Wenjing Shi, Fang Zhang, Xiaozheng Chen et al. · Cancer Science · 2022 · 36 citations · Full text

Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm).

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2021 · 31 citations

Pathology, First-line Treatment, Pharmacotherapy +22

Good Thermoelectric Performance in Strongly Correlated System SnCCo₃ with Antiperovskite Structure

Shuai Lin, Peng Tong, Bosen Wang et al. · Inorganic Chemistry · 2014 · 29 citations

Magnetic Properties, Antiperovskite Structure, Engineering +21